Possible adverse reactions after taking meloxicam and rizatriptan combination tablets (meloxicam and rizatriptan)

Meloxicam and rizatriptan combination tablets (meloxicam and rizatriptan rizatriptan) is a drug used to treat acute attacks of migraine in adults. Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) with analgesic and anti-inflammatory effects, while rizatriptan is a 5- serotonin receptor agonist that can relieve migraine symptoms by acting on intracranial blood vessels and the trigeminal nervous system. This drug is indicated for patients with migraines with or without aura, but is not indicated for the preventive treatment of migraines or cluster headaches. Although its efficacy is significant, some adverse reactions may occur during use, and patients need to understand the related risks and take appropriate countermeasures.

People may experience a variety of side effects after taking meloxicam and rizatriptan. Common adverse reactions include headache, dizziness, fatigue, nausea, etc. These symptoms are usually mild and short-lived. However, some patients may experience more serious side effects, such as cardiovascular events (such as myocardial ischemia, arrhythmia), hypertension, gastrointestinal discomfort (such as abdominal pain, indigestion), and allergic reactions (such as rash, itching). Additionally, serious skin reactions, hepatotoxicity, or renal impairment may occur in rare cases, especially with long-term or high-dose use. The risk of side effects may be further increased in elderly patients, those with compromised renal function, or those taking other medications (e.g., diuretics, ACEinhibitors) concurrently.

When adverse reactions occur, patients should take appropriate countermeasures based on the severity of the symptoms. For minor headaches or nausea, rest and see if symptoms subside. If severe chest pain, difficulty breathing, persistent vomiting, or skin allergic reaction occurs, discontinue medication and seek medical attention immediately. For patients who use this drug for a long time, it is recommended that blood pressure, liver function, and kidney function be monitored regularly to detect potential problems in time. In addition, patients should avoid drinking alcohol or taking other drugs that may increase the risk of side effects, such as aspirin or other NSAIDs while taking the drug.

There are some special precautions that need to be taken when using meloxicam and rizatriptan. First, the drug is contraindicated in patients with severe cardiovascular disease, uncontrolled hypertension, peripheral vascular disease, or hypersensitivity to the components of the drug. Secondly, pregnant women, lactating women, and pediatric patients should use it with caution under the guidance of a doctor, because the relevant safety data are not yet sufficient. For the elderly or those with hepatic or renal impairment, dose adjustment or use may need to be avoided. Finally, patients should avoid engaging in activities that require a high degree of concentration, such as driving or operating machinery, to prevent dizziness or fatigue from causing accidents while taking the medication.

In short, meloxicam and rizatriptan combination tablets have significant effects in the treatment of migraine, but patients need to fully understand their possible adverse reactions and precautions. Through rational medication use, close monitoring and timely response, the risk of side effects can be minimized and the safety and effectiveness of treatment can be ensured.

Reference link:https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/215431s000lbl.pdf